Consistent with previous studies, analysis of NAA10 expression in the TCGA and CPTAC datasets also revealed that NAA10 mRNA or protein levels are substantially higher in tumors with advanced stage or grade in several cancer types, such as liver cancer in the TCGA dataset and lung adenocarcinoma in the CPTAC dataset [29,30,32,35,92]. The gene discussed is NAA10; the disease is lung adenocarcinoma.